In: Finance
B. Vanduard Pharmaceuticals' partial balance sheets are
shown below. Vanguard issued $10,000,000 of new common stock in the
most recent year. Using this information and the results from part
a, fill in the missing values for common stock, retained earnings,
total common equity, and total liabilities and
equity.
|
2016 | 2015 | |
Assets | ||
Cash and cash equivalents | $102,805 | $74,625 |
Short-term investments | 11,400 | 15,100 |
Accounts Receivable | 108,470 | 85,527 |
Inventories | 38,450 | 34,982 |
Total current assets | $261,125 | $210,234 |
Net fixed assets | 100,500 | 42,436 |
Total assets | $361,625 | $252,670 |
Liabilities and equity | ||
Accounts payable | $30,761 | $23,109 |
Accruals | 30,405 | 22,656 |
Notes payable | 12,717 | 14,217 |
Total current liabilities | $73,883 | $59,982 |
Long-term debt | 80,263 | 63,914 |
Total liabilities | $154,146 | $123,896 |
Common stock | $100,000 | $90,000 |
Retained earnings | $107,479 | 38,774 |
Total common equity | $207,479 | $128,774 |
Total liabilities and equity | $361,625 | $252,670 |
Note : | ||
1 ) total liability and equity = total asset | $361,625 | |
2) total common equity= total liability and equity - total liability = $361,625-$154,146 = $207,749 | $207,479 | |
3) common equity= Last year equity + Fresh issue = $90000+$10000 | $100,000 | |
4) Retained earning = Total common equity- Common equity = $207,479-$100,000 | $107,479 |